SequelSEC

GLAUKOS Corp GKOS

Surgical & Medical Instruments & Apparatus · CIK 0001192448 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$690.33M
Fiscal year ended 2026-09-30
Operating income
-$176.16M
Fiscal year ended 2026-09-30
Free cash flow
$36.02M
Fiscal year ended 2026-09-30

Valuation, from the filing

Public float$5.91BMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$101.81Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue11.7×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity9.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth32.3%76th
Current ratio4.69x72th
CapEx / revenue1.5%34th
SBC / revenue12.5%63th
Gross margin55.7%38th
Net margin-37.0%42th
Operating margin-39.3%42th
FCF margin-4.4%54th

GLAUKOS Corp (GKOS) reported revenue of $690.33M and net income of -$169.80M for the fiscal year ended 2026-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from GLAUKOS Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

GLAUKOS Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Revenue$690.33M
Cost of revenue$130.29M
Gross profit$447.18M
Operating income-$176.16M
Net income-$169.80M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$174.52M
Income tax expense-$4.72M
Diluted EPSUnavailable
Selling, general & administrative$434.65M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

GLAUKOS Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Cash & equivalents$162.33M
Total assets$979.53M
Current assets$579.65M
Total liabilities$262.26M
Current liabilities$126.73M
Total equity incl. NCI$717.27M
Temporary (mezzanine) equityUnavailable
Inventory$61.03M
Accounts receivable$150.00M
Goodwill$66.71M
Long-term debtUnavailable
Accounts payable$24.41M

Cash flow

GLAUKOS Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Operating cash flow$47.71M
Capital expenditures$11.69M
Investing cash flow-$16.23M
Financing cash flow$33.87M
Net change in cash$63.36M
Stock-based compensation$83.08M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$41.78M

Derived

GLAUKOS Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Free cash flow$36.02M
Gross margin64.8%
Operating margin-25.5%
FCF margin5.2%
SBC / revenue12.0%
Current ratio4.57x
Revenue YoY growth46.9%
Net margin-24.6%
R&D / revenueUnavailable
CapEx / revenue1.7%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GKOS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-28View SEC filing
10-Q · Filed 2026-07-29View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-23View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-04View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.